TNF and COVID-19: A large study at the Mount Sinai Institute of New York followed up with 1484 patients hospitalized for suspected or confirmed COVID-19 up to 41 days after admission: IL-6 and TNF-alpha at the time of hospitalization confirmed their predictive value on disease severity and death risk.